← Eichor
Study identifier: NCT04579588 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Condition: Corona Virus Infection · Flu Vaccine · Immunity  ·  Sponsor: Stanford University

PhaseN/A
Planned participants230
Who can joinAll sexes, 9 Years to 64 Years
Healthy volunteersYes

About this study

The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

This description comes directly from the study's public registry record.

Talk to the study team

SNP Center Inquiry  ·  (650) 521-7237  ·  snpcenterallergy_inquiry@stanford.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Stanford UniversityPalo Alto, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04579588